We've Come to the End of the Road: FY 2018 Report to Congress Says DCAA Backlog is No More
Client Alert | less than 1 min read | 07.11.19
The Defense Contract Audit Agency (DCAA) recently made public its Fiscal Year (FY) 2018 Report to Congress (“Report”), which, among other things, reports that DCAA has eliminated its incurred cost audit backlog.
The Report also describes its industry outreach activities and DCAA’s plans to focus more attention on other audits, such as business systems, Truth in Negotiations Act, Cost Accounting standards, pre-award surveys, claims, and terminations. Those plans are discussed more fully in our blog post.
Contacts
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
